Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery

November 23, 2023 updated by: Francesco Montorsi, IRCCS San Raffaele

Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery. Long-term Evaluation of the Course of Prostate Cancer Associated With Quality of Life, Post-surgery Treatments and Occurrence of Any Disease Recurrence

This is a single-center, observational, prospective study on quality of life and disease status of patients who underwent radical prostatectomy. Data related to clinical conditions (oncological, psychological, sexual and quality of life) of these patients are collected in a database.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

A database was created with the intention of collecting data related to patients with diagnosis of prostate cancer who underwent radical prostatectomy.

Anamnesis, surgery, histological report and hospitalization data are collected for patients who underwent radical prostatectomy.

Each patient will be followed for 10 years from the date of radical prostatectomy surgery.

Each patient will receive a questionnaire before radical prostatectomy in order to evaluate the quality of life (urinary continence, erectile function and psycho-physical wellbeing). A follow up questionnaire will be collected after surgery in order to analyze the predictive factors of the disease, clinical progression and to obtain health benefits for the patients involved and for future patients with the same tipe of cancer, improving the scientific knowledge of the pathology and implementing new strategies for diagnosis and therapy and evaluating the epidemiologic changes of prostate cancer. Tha data collected will be handles following the most strict Good Clinical Practice (GCPs) and privacy norms.

Study Type

Observational

Enrollment (Actual)

1784

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy
        • Francesco Montorsi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with a diagnosis of prostate cancer who need to undergo radical prostatectomy surgery

Description

Inclusion Criteria:

  • Patients with prostate cancer who underwent radical prostatectomy;
  • Adult patients > 18 years
  • Ability to read and sign the informed consent

Exclusion Criteria:

  • Patients < 18 years
  • mental or physical disability that may prevent the patient from satisfying the requirements of the protocol
  • Inability to read and sign the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients referred to the Urology Department who need to undergo radical prostatectomy surgery
Radical Prostatectomy: surgery to remove the prostate gland and seminal vesicles (and sometimes nearby lymph nodes) after a prostate cancer diagnosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Early Urinary continence recovery
Time Frame: 6 months after the intervention/procedure/surgery
Continence recovery evaluated with the International Consultation on Incontinence questionnaire - short form (ICIQ-SF), International Prostatic Symptoms Score (IPSS) questionnaires
6 months after the intervention/procedure/surgery
Early Erectile function recovery
Time Frame: 6 months after the intervention/procedure/surgery
Erectile function recovery evaluated with the International Index of Erectile Function (IIEF) questionnaire
6 months after the intervention/procedure/surgery
Prostate-specific antigen (PSA) persistence or biochemical recurrence
Time Frame: 6 months and every year after the intervention/procedure/surgery up to 10 years
Serum PSA levels, conventional imaging
6 months and every year after the intervention/procedure/surgery up to 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary continence recovery
Time Frame: every year after the intervention/procedure/surgery up to 10 years
Continence recovery evaluated with the International Consultation on Incontinence
every year after the intervention/procedure/surgery up to 10 years
Erectile function recovery
Time Frame: every year after the intervention/procedure/surgery up to 10 years
Erectile function recovery evaluated with the International Index of Erectile Function (IIEF)
every year after the intervention/procedure/surgery up to 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2004

Primary Completion (Estimated)

February 13, 2025

Study Completion (Estimated)

February 13, 2025

Study Registration Dates

First Submitted

October 13, 2023

First Submitted That Met QC Criteria

November 23, 2023

First Posted (Actual)

December 4, 2023

Study Record Updates

Last Update Posted (Actual)

December 4, 2023

Last Update Submitted That Met QC Criteria

November 23, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostate Cancer

Clinical Trials on Radical prostatectomy

3
Subscribe